Morocco medicine price database

AMGEVITA 40 MG

adalimumab

Public price

4.817,00 MAD

Active substance

adalimumab

Laboratory

AMANYS PHARMA (Ex SAHAM PHARMA)

What is this medicine?

HADLIMA (adalimumab-bwwd) is a biosimilar to HUMIRA (adalimumab) that acts as a tumor necrosis factor (TNF) blocker.

Verified summary

adalimumab, Solution injectable, 40 MG, Boite de 2 seringues pré-remplies

Common uses

moderately to severely active rheumatoid arthritis,moderately to severely active polyarticular juvenile idiopathic arthritis,active psoriatic arthritis,active ankylosing spondylitis,moderately to severely active Crohn’s disease,moderately to severely active ulcerative colitis,moderate to severe chronic plaque psoriasis,moderate to severe hidradenitis suppurativa,non-infectious intermediate, posterior, and panuveitis

Class

tumor necrosis factor (TNF) blocker

Laboratory

AMANYS PHARMA (Ex SAHAM PHARMA)

Hospital price

4.547,00 MAD

Strength

40 MG

Form

Solution injectable

Presentation

Boite de 2 seringues pré-remplies

ATC code

L04AB04

Type

Générique

Therapeutic class

Inhibiteur du TNF alpha, anticorps monoclonal humain

This information is informational and must be confirmed by a pharmacist or doctor. Do not change medicine or dosage based only on this page.

Price history

Reference price recorded since 2026-06-02: 4.817,00 MAD

Available presentations and strengths

Medicines with the same active substance